NPC-17923

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNPC-17923
Drug Alias NameNPC-17923
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell adhesion molecules inhibitors
TargetsCell adhesion molecules
Therapy Area/IndicationsColitis, UlcerativeArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsColitis, UlcerativeArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A